HIKAL
Back to Balance Sheet
|
HIKAL Last 5 Year Long Term Provisions History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Long Term Provisions | ₹72 Cr | ₹128 Cr | ₹24 Cr | ₹80 Cr | ₹78 Cr |
What is the latest Long Term Provisions ratio of HIKAL ?
| Year | Long Term Provisions |
|---|---|
| Mar2025 | ₹72 Cr |
| Mar2024 | ₹128 Cr |
| Mar2023 | ₹24 Cr |
| Mar2022 | ₹80 Cr |
| Mar2021 | ₹78 Cr |
How is Long Term Provisions of HIKAL Trending?
| Years | Long Term Provisions | % Change | |
|---|---|---|---|
| Mar2025 | ₹72 Cr | -44.07 | |
| Mar2024 | ₹128 Cr | 429.23 | |
| Mar2023 | ₹24 Cr | -69.56 | |
| Mar2022 | ₹80 Cr | 2.11 | |
| Mar2021 | ₹78 Cr | - | |
Compare Long Term Provisions of peers of HIKAL
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| HIKAL | ₹2,670.1 Cr | 0.1% | -11% | -49.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹411,402.0 Cr | 0.5% | -1.5% | -2.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹164,277.0 Cr | 5.5% | -0.2% | 0.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹138,140.0 Cr | 2.1% | 2.8% | 30.9% | Stock Analytics | |
| CIPLA | ₹107,398.0 Cr | 1.3% | -7.9% | -6.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,378.0 Cr | 2% | 4.5% | 2.3% | Stock Analytics | |
HIKAL Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| HIKAL | 0.1% |
-11% |
-49.5% |
| SENSEX | 0.4% |
-0.2% |
6.9% |
You may also like the below Video Courses